This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

RCUS Insider Trading

Insider Ownership Percentage: 13.80%
Insider Buying (Last 12 Months): $339,452,595.00
Insider Selling (Last 12 Months): $3,120,291.23

Arcus Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Arcus Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arcus Biosciences Share Price & Price History

Current Price: $19.10
Price Change: Price Decrease of -0.03 (-0.16%)
As of 03/1/2024 01:00 AM ET

This chart shows the closing price history over time for RCUS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

Arcus Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85274,323View SEC Filing Icon  
2/26/2024Juan C. JaenPresidentSell3,900$20.06$78,234.001,211,365View SEC Filing Icon  
1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.0030,061,124View SEC Filing Icon  
1/2/2024Juan C. JaenPresidentSell6,975$20.09$140,127.751,215,265View SEC Filing Icon  
1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.0051,831View SEC Filing Icon  
12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96258,878View SEC Filing Icon  
9/22/2023Jennifer JarrettCOOSell21,369$19.99$427,166.31302,691View SEC Filing Icon  
7/28/2023Jennifer JarrettCOOSell45,000$20.25$911,250.00336,566View SEC Filing Icon  
7/3/2023Alexander AzoyCAOSell1,018$20.41$20,777.3811,596View SEC Filing Icon  
6/28/2023Gilead Sciences, Inc.Major ShareholderBuy1,010,000$19.26$19,452,600.0014,823,029View SEC Filing Icon  
6/22/2023Jennifer JarrettCOOSell12,437$19.12$237,795.44381,566View SEC Filing Icon  
6/16/2023Jennifer JarrettCOOSell12,563$19.35$243,094.05394,003View SEC Filing Icon  
3/16/2023Jennifer JarrettCOOSell8,729$16.81$146,734.49406,217View SEC Filing Icon  
1/26/2023Jennifer JarrettCOOSell300$23.56$7,068.00416,546View SEC Filing Icon  
12/16/2022Carolyn C TangGeneral CounselSell2,523$30.75$77,582.2528,584View SEC Filing Icon  
12/16/2022Jennifer JarrettCOOSell16,482$30.75$506,821.50147,609View SEC Filing Icon  
12/16/2022Juan C. JaenPresidentSell4,436$30.75$136,407.00218,258View SEC Filing Icon  
12/16/2022Robert C Goeltz IICFOSell2,453$30.75$75,429.7511,566View SEC Filing Icon  
12/16/2022Terry J. RosenCEOSell13,043$30.75$401,072.25242,173View SEC Filing Icon  
9/16/2022Jennifer JarrettCOOSell12,677$26.28$333,151.56130,942View SEC Filing Icon  
6/16/2022Carolyn C TangGeneral CounselSell1,400$20.72$29,008.0025,431View SEC Filing Icon  
6/16/2022Jennifer JarrettCOOSell6,081$20.72$125,998.32125,233View SEC Filing Icon  
6/16/2022Juan C. JaenPresidentSell2,333$20.72$48,339.76212,574View SEC Filing Icon  
6/16/2022Terry J. RosenCEOSell4,241$20.72$87,873.52232,329View SEC Filing Icon  
3/16/2022Jennifer JarrettCOOSell9,617$31.62$304,089.54View SEC Filing Icon  
12/20/2021Jennifer JarrettCOOSell34,822$41.48$1,444,416.56View SEC Filing Icon  
12/16/2021Carolyn C TangGeneral CounselSell487$39.82$19,392.34View SEC Filing Icon  
12/16/2021Jennifer JarrettCOOSell5,560$39.82$221,399.20View SEC Filing Icon  
12/16/2021Juan C. JaenPresidentSell865$39.82$34,444.30View SEC Filing Icon  
12/16/2021Robert C Goeltz IICFOSell485$39.83$19,317.55View SEC Filing Icon  
12/16/2021Terry J. RosenCEOSell2,299$39.82$91,546.18View SEC Filing Icon  
9/20/2021Jennifer JarrettCOOSell30,634$35.18$1,077,704.12View SEC Filing Icon  
6/16/2021Carolyn C. TangGeneral CounselSell1,309$24.16$31,625.44View SEC Filing Icon  
6/4/2021Jennifer JarrettCOOSell1,044$24.91$26,006.04View SEC Filing Icon  
4/23/2021Yasunori KanekoDirectorBuy4,133$31.37$129,652.216,717View SEC Filing Icon  
3/31/2021Kathryn E FalbergDirectorBuy20,000$28.35$567,000.0080,504View SEC Filing Icon  
3/16/2021Jennifer JarrettCOOSell8,661$35.03$303,394.83116,973View SEC Filing Icon  
3/16/2021William GrossmanInsiderSell2,127$35.03$74,508.8110,850View SEC Filing Icon  
See Full Table
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

SEC Filings (Institutional Ownership Changes) for Arcus Biosciences (NYSE:RCUS)

74.67% of Arcus Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCUS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arcus Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/1/2024Goldman Sachs Group Inc.592,291$11.31M0.0%+0.7%0.652%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD32,858$0.63M0.0%+5.3%0.044%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP90,873$1.74M0.1%+329.9%0.121%Search for SEC Filing on Google Icon
2/16/2024Public Employees Retirement System of Ohio10,787$0.21M0.0%+439.4%0.014%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc148,930$2.85M0.0%-0.8%0.199%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC202,893$3.88M0.0%-56.9%0.271%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.4,680,716$89.40M0.0%+4.2%6.253%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC133,447$2.55M0.0%-71.2%0.178%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP1,868,000$35.68M5.7%-5.1%2.495%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD32,858$0.63M0.0%+5.3%0.044%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC43,165$0.82M0.0%-15.5%0.058%Search for SEC Filing on Google Icon
2/15/2024Public Sector Pension Investment Board111,846$2.14M0.0%+68.7%0.149%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC247,664$4.73M0.7%+20.7%0.331%Search for SEC Filing on Google Icon
2/15/2024Gilder Gagnon Howe & Co. LLC139,170$2.66M0.0%-41.7%0.186%Search for SEC Filing on Google Icon
2/15/2024Granahan Investment Management LLC230,777$4.41M0.1%+18.0%0.308%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada5,229$100K0.0%+28,950.0%0.007%Search for SEC Filing on Google Icon
2/14/2024Point72 Asset Management L.P.768,750$14.68M0.0%+17,148.1%1.027%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP23,700$0.45M0.1%N/A0.032%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.515,453$9.85M0.0%+11.0%0.689%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.97,435$1.86M0.8%-74.0%0.130%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp524,689$10.02M0.0%+1.4%0.701%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 2,514$48K0.0%-47.4%0.003%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.592,291$11.31M0.0%+0.7%0.791%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC251,404$4.80M0.0%-14.1%0.336%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC11,141$0.21M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/13/2024KBC Group NV1,952$37K0.0%-51.5%0.003%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC62,894$1.20M0.1%N/A0.084%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System51,988$0.99M0.0%-3.1%0.069%Search for SEC Filing on Google Icon
2/12/2024Alpha DNA Investment Management LLC28,690$0.55M0.2%+11.6%0.038%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC10,643$0.20M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/12/2024Decheng Capital LLC869,790$16.61M4.6%N/A1.162%Search for SEC Filing on Google Icon
2/12/2024Allianz Asset Management GmbH23,300$0.45M0.0%-37.0%0.031%Search for SEC Filing on Google Icon
2/12/2024Cape Investment Advisory Inc.4,045$77K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE8,661$0.17M0.0%+353.5%0.012%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC4,013$77K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP43,537$0.83M0.0%-44.6%0.058%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG162,484$3.10M0.0%+182.4%0.217%Search for SEC Filing on Google Icon
2/9/2024PNC Financial Services Group Inc.1,507$29K0.0%-61.4%0.002%Search for SEC Filing on Google Icon
2/9/2024Norges Bank79,824$1.53M0.0%N/A0.107%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.228,996$4.37M0.0%+130.6%0.306%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA56,346$1.08M0.0%-3.1%0.075%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.332,814$6.36M0.0%+1.0%0.445%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP1,594,609$30.46M0.0%+11.0%2.130%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets110,366$2.11M0.0%+32.5%0.147%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas11,155$0.21M0.0%-17.3%0.015%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.13,501$0.26M0.0%-10.2%0.018%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.472,182$9.02M0.0%+2.5%0.631%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank21,027$0.40M0.0%-4.4%0.028%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank95,396$1.82M0.0%-8.6%0.127%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.104,413$1.99M0.0%+53.3%0.139%Search for SEC Filing on Google Icon
2/5/2024Mach 1 Financial Group LLC25,314$0.48M0.2%+11.2%0.034%Search for SEC Filing on Google Icon
2/1/2024Yousif Capital Management LLC27,094$0.52M0.0%-5.6%0.036%Search for SEC Filing on Google Icon
2/1/2024GAMMA Investing LLC1,601$31K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB12,800$0.24M0.0%N/A0.017%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 18,883$0.36M0.0%+37.5%0.025%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio8,300$0.16M0.0%+245.8%0.011%Search for SEC Filing on Google Icon
1/29/2024Louisiana State Employees Retirement System27,000$0.52M0.0%N/A0.036%Search for SEC Filing on Google Icon
1/25/2024Allspring Global Investments Holdings LLC11,850$0.23M0.0%+27.0%0.016%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.30,654$0.59M0.0%-2.7%0.041%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.47,253$0.90M0.0%N/A0.063%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC20,568$0.39M0.0%N/A0.027%Search for SEC Filing on Google Icon
1/10/2024Nordea Investment Management AB205,428$3.95M0.0%-3.0%0.274%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC6,816$0.13M0.0%+34.0%0.009%Search for SEC Filing on Google Icon
12/19/2023Public Employees Retirement System of Ohio2,000$36K0.0%N/A0.003%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.4,493,818$80.66M0.0%+1.4%6.003%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP80,000$1.44M0.0%-30.4%0.107%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.145,729$2.62M0.0%+20.8%0.195%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.457,695$8.22M0.0%+3.0%0.611%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG26,854$0.48M0.0%+14.4%0.036%Search for SEC Filing on Google Icon
11/22/2023Public Sector Pension Investment Board66,302$1.19M0.0%-29.0%0.089%Search for SEC Filing on Google Icon
11/21/2023Comerica Bank24,622$0.44M0.0%+2,827.7%0.033%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.139,059$2.50M0.0%N/A0.186%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al28,173$0.51M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/16/2023Public Employees Retirement System of Ohio2,000$36K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2023The Manufacturers Life Insurance Company 26,806$0.48M0.0%-47.6%0.036%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP21,138$0.38M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.375,456$6.74M1.3%+5.9%0.502%Search for SEC Filing on Google Icon
11/15/2023Seven Eight Capital LP16,265$0.29M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/15/2023Legal & General Group Plc150,195$2.70M0.0%+3.5%0.201%Search for SEC Filing on Google Icon
11/15/2023Alps Advisors Inc.54,951$0.99M0.0%+2.3%0.073%Search for SEC Filing on Google Icon
11/15/2023Ameriprise Financial Inc.1,579,924$28.36M0.0%+6.9%2.111%Search for SEC Filing on Google Icon
11/14/2023Lazard Asset Management LLC3,960$71K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC142,900$2.57M0.0%-21.9%0.191%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System53,638$0.96M0.0%-4.4%0.072%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 4,784$86K0.0%-35.2%0.006%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP78,637$1.41M0.0%N/A0.105%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC51,071$0.92M0.1%-9.4%0.068%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC72,018$1.29M0.1%+15.8%0.096%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp517,484$9.29M0.0%+2.0%0.691%Search for SEC Filing on Google Icon
11/13/2023Dark Forest Capital Management LP38,224$0.69M0.1%N/A0.051%Search for SEC Filing on Google Icon
11/13/2023Invesco Ltd.232,804$4.18M0.0%-6.6%0.311%Search for SEC Filing on Google Icon
11/13/2023FMR LLC4,780,052$85.80M0.0%+4.9%6.385%Search for SEC Filing on Google Icon
11/13/2023Nordea Investment Management AB211,784$3.79M0.0%+12.9%0.283%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC292,708$5.25M0.0%-2.5%0.391%Search for SEC Filing on Google Icon
11/13/2023E Fund Management Co. Ltd.15,038$0.27M0.0%-6.8%0.020%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers169,849$3.05M0.0%+2.5%0.228%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG26,854$0.48M0.0%+14.4%0.036%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.145,729$2.62M0.0%+20.8%0.196%Search for SEC Filing on Google Icon
11/9/2023Commonwealth of Pennsylvania Public School Empls Retrmt SYS35,863$0.64M0.0%-39.7%0.048%Search for SEC Filing on Google Icon
11/9/2023Texas Permanent School Fund Corp45,538$0.82M0.0%-1.7%0.061%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arcus Biosciences logo
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's pipeline products include Domvanalimab, an anti-TIGIT investigational monoclonal antibody, which is in Phase 2 and Phase 3 clinical trial; and AB308, an investigational anti-TIGIT monoclonal antibody, which is in Phase 1b clinical trial to study people with advanced solid and hematologic malignancies. It also develops Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in Phase 2 clinical trial; Quemliclustat, a small-molecule CD73 inhibitor, which is Phase 1b and Phase 2 clinical trial; Zimberelimab, an anti-PD-1 antibody, which is in Phase 2 clinical trial for metastatic cell lung cancer and monotherapy; and AB521, an oral and small-molecule inhibitor of HIF-2a, which is in Phase 1 clinical trial for the treatment of Von Hippel-Lindau disease. In addition, the company's preclinical pipeline products include AB598, a CD39 antibody; and AB801, a small molecule Axl inhibitor. It has a clinical collaboration with AstraZeneca to evaluate domvanalimab in combination with durvalumab in a registrational phase 3 clinical trial in patients with unresectable Stage 3 NSCLC; and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is headquartered in Hayward, California.
Read More on Arcus Biosciences

Today's Range

Now: $19.10
Low: $18.95
High: $19.60

50 Day Range

MA: $17.19
Low: $14.82
High: $20.18

52 Week Range

Now: $19.10
Low: $12.95
High: $25.47

Volume

877,827 shs

Average Volume

1,000,164 shs

Market Capitalization

$1.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of Arcus Biosciences?

Arcus Biosciences' top insider shareholders include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Juan C Jaen (President)
  3. Jennifer Jarrett (COO)
  4. Terry J Rosen (CEO)
  5. Robert C Goeltz II (CFO)
  6. Carolyn C Tang (General Counsel)
  7. Alexander Azoy (CAO)
Learn More about top insider investors at Arcus Biosciences.

Who are the major institutional investors of Arcus Biosciences?

Arcus Biosciences' top institutional shareholders include:
  1. Vanguard Group Inc. — 6.25%
  2. Octagon Capital Advisors LP — 2.50%
  3. Dimensional Fund Advisors LP — 2.13%
  4. Decheng Capital LLC — 1.16%
  5. Point72 Asset Management L.P. — 1.03%
  6. Goldman Sachs Group Inc. — 0.79%
Learn More about top institutional investors of Arcus Biosciences stock.

Which major investors are selling Arcus Biosciences stock?

In the previous quarter, RCUS stock was sold by these institutional investors:
  1. Nuveen Asset Management LLC
  2. Sectoral Asset Management Inc.
  3. Barclays PLC
  4. Octagon Capital Advisors LP
  5. Gilder Gagnon Howe & Co. LLC
  6. Rafferty Asset Management LLC
  7. Trexquant Investment LP
  8. Simplex Trading LLC
Within the previous year, company insiders that have sold Arcus Biosciences company stock include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Juan C Jaen (President)
  3. Jennifer Jarrett (COO)
  4. Terry J Rosen (CEO)
Learn More investors selling Arcus Biosciences stock.

Which major investors are buying Arcus Biosciences stock?

During the previous quarter, RCUS stock was bought by institutional investors including:
  1. Decheng Capital LLC
  2. Point72 Asset Management L.P.
  3. Vanguard Group Inc.
  4. Dimensional Fund Advisors LP
  5. Panagora Asset Management Inc.
  6. UBS Group AG
  7. Norges Bank
  8. GSA Capital Partners LLP
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.